Cefdinir Use in the Kentucky Medicaid Population: A Priority for Outpatient Antimicrobial Stewardship | Zendy

Bethany A. Wattles | Zendy; Navjyot K. Vidwan | Zendy; Soutik Ghosal | Zendy; Yana Feygin | Zendy; Liza Creel | Zendy; John Myers | Zendy; Charles R. Woods | Zendy; Michael J. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cefdinir Use in the Kentucky Medicaid Population: A Priority for Outpatient Antimicrobial Stewardship

Author(s) -

Bethany A. Wattles,

Navjyot K. Vidwan,

Soutik Ghosal,

Yana Feygin,

Liza Creel,

John Myers,

Charles R. Woods,

Michael J. Smith

Publication year - 2019

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piz084

Subject(s) - cefdinir , medicine , medicaid , antimicrobial stewardship , medical prescription , stewardship (theology) , population , family medicine , pharmacology , cephalosporin , environmental health , antibiotics , health care , antibiotic resistance , politics , political science , law , microbiology and biotechnology , economics , biology , economic growth

Cefdinir is frequently prescribed for pediatric infections despite lack of first-line indications. We reviewed Kentucky Medicaid claims from 2012 through 2016. Cefdinir prescriptions and spending significantly increased over the study period. Upper respiratory infections accounted for the majority of use. Inappropriate cefdinir use should be a priority for stewardship efforts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research